ClinConnect ClinConnect Logo
Search / Trial NCT03994042

Mental Imagery Neurofeedback in Strokerehabilitation

Launched by MÄLARDALEN UNIVERSITY · Jun 19, 2019

Trial Information

Current as of July 08, 2025

Completed

Keywords

ClinConnect Summary

This study will be carried out as a pilot study in order to optimize and set parameters for a subsequent study that will involve more stroke patients. Stroke patients will be trained to mentally imagine the opening and closing of the hand (hereafter named MI, Motor Imagery). During the training, the patients will receive visual feedback in real time that reflects the neural activity related to motor processes. The NeuroFeedback (NF) will be projected with minimal time delay to maximize the neural learning. This type of brain training with feedback is thought to have significant importance t...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • More than 6 months since first time stroke onset and with remaining hemiparesis in upper extremity;
  • able to participate fully in the intervention including screening of cognitive function with the Cambridge Neuropsychological Test Automated Battery;
  • able to perform Functional Magnetic Resonance Imaging (fMRI);
  • able to passively extend the wrist 15 degrees and extend fingers fully with a neutral position of the wrist.
  • Subgroup 1 (n=2):
  • be able to voluntarily control the power of their grip when requested according to the Visuomotor force tracking method and/or according to the clinical assessment of a therapist (while holding the patient´s hand).
  • Fugl-Meyer Upper Extremity (UE) scale (Fugl-Meyer 1975): \<14 points on the hand subscale (C) in addition to \< 48 points on the total score (equivalent to moderate disability in the upper extremity
  • Subgroup 2 (n=2):
  • - no detected voluntary grip or release function
  • Exclusion Criteria:
  • Other neurological or musculoskeletal disease/injury, contagious disease or treatment with botulinum toxin in the upper extremity during the past 3 months.
  • current or history of epilepsy, hearing problems, metal implants in the brain/skull cochlear implants, any implanted neurostimulator, cardiac pacemaker or cardiac implants of metal, infusion device.
  • other neurological disorder, pregnancy, current or history of severe psychiatric disorder with need for pharmacological treatment

About Mälardalen University

Mälardalen University is a leading academic institution in Sweden, renowned for its commitment to innovative research and development across various fields, including health sciences. As a clinical trial sponsor, the university leverages its multidisciplinary expertise to advance evidence-based practices and contribute to the understanding of complex health issues. Through collaboration with healthcare professionals and industry partners, Mälardalen University aims to enhance patient care and promote public health by facilitating high-quality clinical research that adheres to rigorous ethical standards and regulatory requirements.

Locations

Stockholm, , Sweden

Stockholm, , Sweden

Västerås, , Sweden

Patients applied

0 patients applied

Trial Officials

Elaine Astrand

Principal Investigator

Mälardalen University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials